GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » ROE % Adjusted to Book Value

MLEC (Moolec Science) ROE % Adjusted to Book Value : -20.76% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moolec Science ROE % Adjusted to Book Value?

Moolec Science's ROE % for the quarter that ended in Sep. 2024 was -122.47%. Moolec Science's PB Ratio for the quarter that ended in Sep. 2024 was 5.90. Moolec Science's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -20.76%.


Moolec Science ROE % Adjusted to Book Value Historical Data

The historical data trend for Moolec Science's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moolec Science ROE % Adjusted to Book Value Chart

Moolec Science Annual Data
Trend Jun21 Jun22 Jun23 Jun24
ROE % Adjusted to Book Value
- - -64.66 -13.98

Moolec Science Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.67 -6.63 -10.79 -24.40 -20.76

Competitive Comparison of Moolec Science's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Moolec Science's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moolec Science's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Moolec Science's ROE % Adjusted to Book Value falls into.



Moolec Science ROE % Adjusted to Book Value Calculation

Moolec Science's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-86.42% / 6.18
=-13.98%

Moolec Science's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-122.47% / 5.90
=-20.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moolec Science ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Moolec Science's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Moolec Science Business Description

Traded in Other Exchanges
N/A
Address
17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.